Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Adv Perit Dial ; 12: 209-10, 1996.
Artigo em Inglês | MEDLINE | ID: mdl-8865904

RESUMO

Persistent exit-site infections and tunnel infections (ESI/TI) are a cause for removal of Swan neck catheters (SNC). Previous studies report variable success in the treatment of these infections by surgical exposure and removal of the subcutaneous external cuff. We report our experience with this technique. All 5 patients with persistent ESI/TI were successfully treated with antibiotics and surgical intervention. All cultures grew Staphylococcus aureus. Average time to complete healing after surgical exposure was 39.4 days. Mean follow-up after complete healing was 164.8 days. There were no subsequent episodes of ESI/TI in these patients. None of the catheters subsequently malfunctioned or developed leaks. Persistent ESI/TI in Swan neck catheters can be successfully treated with surgical exposure and removal of the subcutaneous external cuff.


Assuntos
Cateteres de Demora , Falência Renal Crônica/cirurgia , Diálise Peritoneal/instrumentação , Infecção da Ferida Cirúrgica/cirurgia , Antibacterianos/administração & dosagem , Terapia Combinada , Desbridamento , Humanos , Cicatrização/efeitos dos fármacos
2.
Am J Kidney Dis ; 25(2): 343-5, 1995 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-7847364

RESUMO

Severe metabolic acidosis may occur during hemodialysis when the incorrect acid dialysis concentrate from a two-part bicarbonate dialysis system is used in an acetate dialysis machine. We deliberately applied this technique to correct severe metabolic alkalosis in a patient with chronic renal failure. Rapid correction of the metabolic alkalosis was achieved and the procedure was well tolerated.


Assuntos
Acetatos , Alcalose/terapia , Soluções para Diálise/química , Falência Renal Crônica/complicações , Diálise Renal , Ácido Acético , Humanos , Concentração de Íons de Hidrogênio , Falência Renal Crônica/terapia , Masculino , Pessoa de Meia-Idade
3.
J Surg Res ; 51(2): 93-8, 1991 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-1865677

RESUMO

Clinical use of cyclosporin A (CsA) has been associated with platelet hypersensitivity and an increased incidence of thrombotic and vasoactive events. The purpose of this study was (1) to confirm that CsA enhances platelet sensitivity to the soluble agonists, adenosine diphosphate (ADP) and epinephrine (EPI), and (2) to determine if this enhancement is mediated by alteration in the availability of platelet surface fibrinogen receptors, a final mediator of platelet activation. Mean log dose of ADP required to achieve complete second-wave platelet aggregation in vitro decreased from 1.90 to 1.49 microM (n = 19, paired t test, P less than 0.05) and 2.86 to 2.11 microM (n = 16, P less than 0.05) following a 15-min and 3-hr incubation in the absence (saline) and presence of CsA (1000 ng/ml), respectively. At the threshold dose of ADP, concurrent thromboxane B2 levels at 15 min were 245 +/- 44 ng/ml (n = 12, saline) and 265 +/- 54 ng/ml (n = 9, CsA; P greater than 0.05). At 3 hr respective levels were 333 +/- 57 and 442 +/- 81 ng/ml (P greater than 0.05). Similar results were obtained with EPI. The number of fibrinogen binding sites in response to 50 microM ADP was determined in washed platelets in the absence and presence of CsA by radioligand binding. In 6 of 7 volunteers, CsA increased fibrinogen receptors from 26,635 +/- 4841 to 35,925 +/- 7290 sites/platelet (means +/- SEM; P less than 0.05). No change in receptor affinity was noted. In conclusion, cyclosporine does augment platelet reactivity.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Difosfato de Adenosina/farmacologia , Plaquetas/efeitos dos fármacos , Ciclosporinas/farmacologia , Epinefrina/farmacologia , Agregação Plaquetária/efeitos dos fármacos , Glicoproteínas da Membrana de Plaquetas/metabolismo , Plaquetas/metabolismo , Sinergismo Farmacológico , Humanos , Tromboxano B2/metabolismo
5.
Am J Clin Pathol ; 72(4): 597-603, 1979 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-495563

RESUMO

Ten latex-fixation kits (both slide and tube) were evaluated by use of a reference serum containing 250 IU of rheumatoid factor (Communicable Disease Center). All tests were performed with serial dilution of serum; adjacent tubes differed by a factor of 0.10 log10. Geometric titers, means, standard deviations, and variance analysis were used to evaluate commercial kits. Three levels of variance were applied: (1) 0.18 or less for intralaboratory variation when the same serum is tested with the same kit; (2) 0.18-0.35 when various lots or batches of the same serum were used; (3) 1.0 or less when various commercial kits were tested with the same serum. The sensitivity of each commercial kit was determined by assigning to it a value (the minimum detectable unit) arrived at by dividing the number of units in the standard by the titer obtained. The technic presented could be applicable to other serologic tests, and thus provide a general method for their standardization and quality control.


Assuntos
Artrite Reumatoide/sangue , Testes de Fixação do Látex/instrumentação , Fator Reumatoide/análise , Humanos , Testes de Fixação do Látex/normas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...